Package Rates

CARDIOTHORACIC SURGERIES SURGICAL ONCOLOGY MEDICAL ONCOLOGY RADIATION ONCOLOGY PLASTIC SURGERY ORTHOPEDIC TRAUMA POLY TRAUMA
REPLACEMENT PAEDIATRICS NEONATOLOGY PAEDIATRIC INTENSIVE CARE PAEDIATRIC SURGERIES NEUROSURGERY VASCULAR SURGERIES
E N T OPHTHALMOLOGY SURGERIES GYNAECOLOGY OBSTETRIC SURGERY GENERAL MEDICINE PULMONLOGY GASTROENTEROLOGY CARDIOLOGY
NEPHROLOGY NEUROLOGY DERMATOLOGY RHEUMATOLOGY ENDOCRINOLOGY SURGICAL GASTRO ENTEROLOGY CHEST SURGERY
GENITOURINARY SURGERY GENERAL SURGERY HEPATOLOGY INTERVENTIONAL RADIOLOGY TRANSPLANTATION FOLLOW UP PROCEDURE Diagnostic center
STEMI INTERVENTIONAL CARDIOLOGY INFECTIOUS DISEASES - GENERAL MEDICINE HEMATOLOGY PSYCHIATRY OFMS SPINE
ENDOCRINE SURGERY THORACIC MEDICINE          

Package NameCategoryA1A2A3A4 A5A6S1S2
CM0100 : BREAST CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-a : combined regimen AC & T MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-a-I : Dose Dense AC (Adriamycin/Cyclophosphamide) Followed by Paclitaxel MEDICAL ONCOLOGY 2950 2950 2950 2950 2950 2950 2950 2950
CM0100-a-II : Paclitaxel (Preceeded by Dose Dense AC) MEDICAL ONCOLOGY 6000 6000 6000 6000 6000 6000 6000 6000
CM0100-b : TC (Doectaxel & Cyclophosphamide) MEDICAL ONCOLOGY 5950 5950 5950 5950 5950 5950 5950 5950
CM0100-c : CMF (Cyclophosphamide/Methotrexate/Fluorouracil) (includes day 1 & day 8) MEDICAL ONCOLOGY 2650 2650 2650 2650 2650 2650 2650 2650
CM0100-d : EC (Epirubicin/Cyclophosphamide) MEDICAL ONCOLOGY 5050 5050 5050 5050 5050 5050 5050 5050
CM0100-e : FEC + T MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-e-I : FEC/CEF followed by T (Fluorouracil/Epirubicin/Cyclophosphamide) followed by Docetaxel or followed by weekly Paclitaxel) MEDICAL ONCOLOGY 5050 5050 5050 5050 5050 5050 5050 5050
CM0100-e-II : Docetaxel (Preceeded by FEC/CEF ) MEDICAL ONCOLOGY 5450 5450 5450 5450 5450 5450 5450 5450
CM0100-e-III : Paclitaxel - weekly (Preceeded by FEC/CEF ) MEDICAL ONCOLOGY 3500 3500 3500 3500 3500 3500 3500 3500
CM0100-f : FAC + T MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-f-I : FAC followed by T (Fluorouracil/Adriamycin/Cyclophosphamide) followed by weekly Paclitaxel MEDICAL ONCOLOGY 3200 3200 3200 3200 3200 3200 3200 3200
CM0100-f-II : Paclitaxel - weekly Preceeded by FAC MEDICAL ONCOLOGY 3500 3500 3500 3500 3500 3500 3500 3500
CM0100-g : TAC (Docetaxel/Adriamycin/Cyclophosphamide) MEDICAL ONCOLOGY 5550 5550 5550 5550 5550 5550 5550 5550
CM0100-h : AC followed by T + Trastuzumab MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-h-I : AC followed by Paclitaxel + Trastuzumab +/- Pertuzumab MEDICAL ONCOLOGY 2950 2950 2950 2950 2950 2950 2950 2950
CM0100-h-II : Paclitaxel (Preceeded by AC) MEDICAL ONCOLOGY 3500 3500 3500 3500 3500 3500 3500 3500
CM0100-h-III : Trastuzumab (6mg) MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-h-IV : Trastuzumab 4mg (First dose - only) followed by 2mg MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-h-V : Trastuzumab 2mg (Subsequent doses) MEDICAL ONCOLOGY 11500 11500 11500 11500 11500 11500 11500 11500
CM0100-i : TCH MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-i-I : TC (Docetaxel/Carboplatin) with Trastuzumab MEDICAL ONCOLOGY 7050 7050 7050 7050 7050 7050 7050 7050
CM0100-i-II : Trastuzumab (6mg) MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-i-III : Trastuzumab 4mg (First dose - only) followed by 2mg MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-i-IV : Trastuzumab 2mg (Subsequent doses) MEDICAL ONCOLOGY 11500 11500 11500 11500 11500 11500 11500 11500
CM0100-j : AC followed by Docetaxel + Trastuzumab MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-j-I : AC followed by Docetaxel + Trastuzumab MEDICAL ONCOLOGY 2950 2950 2950 2950 2950 2950 2950 2950
CM0100-j-II : Docetaxel (preceeded by AC) + Trastuzumab MEDICAL ONCOLOGY 5350 5350 5350 5350 5350 5350 5350 5350
CM0100-j-III : Trastuzumab (6mg) MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-j-IV : Trastuzumab 4mg (First dose - only) followed by 2mg MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-j-V : Trastuzumab 2mg (Subsequent doses) MEDICAL ONCOLOGY 11500 11500 11500 11500 11500 11500 11500 11500
CM0100-k : Docetaxel + Cyclophosphamide + Trastuzumab MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-k-I : Docetaxel + Cyclophosphamide with Trastuzumab MEDICAL ONCOLOGY 4950 4950 4950 4950 4950 4950 4950 4950
CM0100-k-II : Trastuzumab (6mg) MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-k-III : Trastuzumab 4mg (First dose - only) followed by 2mg MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-k-IV : Trastuzumab 2mg (Subsequent doses) MEDICAL ONCOLOGY 11500 11500 11500 11500 11500 11500 11500 11500
CM0100-L : Paclitaxel + Trastuzumab MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-L-I : Paclitaxel (with Trastuzumab) MEDICAL ONCOLOGY 3000 3000 3000 3000 3000 3000 3000 3000
CM0100-L-II : Trastuzumab (6mg) MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-L-III : Trastuzumab 4mg (First dose - only) followed by 2mg MEDICAL ONCOLOGY 30500 30500 30500 30500 30500 30500 30500 30500
CM0100-L-IV : Trastuzumab 2mg (Subsequent doses) MEDICAL ONCOLOGY 11500 11500 11500 11500 11500 11500 11500 11500
CM0100-M : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0101 : BLADDER CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0101-a-I : DDMVAC MEDICAL ONCOLOGY 3740 3740 3740 3740 3740 3740 3740 3740
CM0101-a-II : Gemcitabine + cisplatin MEDICAL ONCOLOGY 6310 6310 6310 6310 6310 6310 6310 6310
CM0101-a-III : Cisplatin + methotrexate + vinblastine (CMV) MEDICAL ONCOLOGY 2710 2710 2710 2710 2710 2710 2710 2710
CM0101-b : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0102 : LUNG CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0102-i : Mesothelioma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0102-i-a : Pemetrexed + cisplatin MEDICAL ONCOLOGY 14500 14500 14500 14500 14500 14500 14500 14500
CM0102-i-b : Pemetrexed + carboplatin MEDICAL ONCOLOGY 16450 16450 16450 16450 16450 16450 16450 16450
CM0102-i-c : Cisplatin & Gemcitabine MEDICAL ONCOLOGY 7515 7515 7515 7515 7515 7515 7515 7515
CM0102-i-d : Vinorelbine MEDICAL ONCOLOGY 8950 8950 8950 8950 8950 8950 8950 8950
CM0102-i-e : Pemetrexed MEDICAL ONCOLOGY 14150 14150 14150 14150 14150 14150 14150 14150
CM0102-i-f : Gemcitabine MEDICAL ONCOLOGY 7520 7520 7520 7520 7520 7520 7520 7520
CM0102-i-g : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0102-ii : NSCLC MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0102-ii-a : Cisplatin & Vinorelbine - (i) MEDICAL ONCOLOGY 33550 33550 33550 33550 33550 33550 33550 33550
CM0102-ii-b : Cisplatin & Vinorelbine - (ii) MEDICAL ONCOLOGY 17900 17900 17900 17900 17900 17900 17900 17900
CM0102-ii-c : Cisplatin & Etoposide MEDICAL ONCOLOGY 4880 4880 4880 4880 4880 4880 4880 4880
CM0102-ii-d : Cisplatin & Docetaxel MEDICAL ONCOLOGY 6250 6250 6250 6250 6250 6250 6250 6250
CM0102-ii-e : Cisplatin & Gemcitabine MEDICAL ONCOLOGY 6010 6010 6010 6010 6010 6010 6010 6010
CM0102-ii-f : Pemetrexed + cisplatin MEDICAL ONCOLOGY 14500 14500 14500 14500 14500 14500 14500 14500
CM0102-ii-g : Paclitaxel/Carboplatin MEDICAL ONCOLOGY 8050 8050 8050 8050 8050 8050 8050 8050
CM0102-ii-h : Cisplatin & Etoposide MEDICAL ONCOLOGY 8450 8450 8450 8450 8450 8450 8450 8450
CM0102-ii-i : Cisplatin & Vinblastine MEDICAL ONCOLOGY 8200 8200 8200 8200 8200 8200 8200 8200
CM0102-ii-j : Carboplatin + Pemetrexed MEDICAL ONCOLOGY 16450 16450 16450 16450 16450 16450 16450 16450
CM0102-ii-k : Cisplatin + Pemetrexed MEDICAL ONCOLOGY 14900 14900 14900 14900 14900 14900 14900 14900
CM0102-ii-l : Paclitaxel + Carboplatin MEDICAL ONCOLOGY 3230 3230 3230 3230 3230 3230 3230 3230
CM0102-ii-m : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0102-iii : LUNG CANCER - NSCLC MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0102-iii-a : Cisplatin & Etoposide MEDICAL ONCOLOGY 4880 4880 4880 4880 4880 4880 4880 4880
CM0102-iii-b : Carboplatin & Etoposide MEDICAL ONCOLOGY 6430 6430 6430 6430 6430 6430 6430 6430
CM0102-iii-c : Cisplatin + Irinotecan MEDICAL ONCOLOGY 5790 5790 5790 5790 5790 5790 5790 5790
CM0102-iii-d : Cisplatin + Irinotecan MEDICAL ONCOLOGY 5670 5670 5670 5670 5670 5670 5670 5670
CM0102-iii-e : Carboplatin & Irinotecan MEDICAL ONCOLOGY 7640 7640 7640 7640 7640 7640 7640 7640
CM0102-iii-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0103-i : ESOPHAGEAL CANCER - Neo Adjuvant MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0103-i-a : Paclitaxel + Carboplatin MEDICAL ONCOLOGY 3230 3230 3230 3230 3230 3230 3230 3230
CM0103-i-b : Fluorouracil & Cisplatin MEDICAL ONCOLOGY 11980 11980 11980 11980 11980 11980 11980 11980
CM0103-i-c : Fluorouracil & Cisplatin MEDICAL ONCOLOGY 7050 7050 7050 7050 7050 7050 7050 7050
CM0103-i-d : Fluorouracil + Oxaliplatin + Leucovorin MEDICAL ONCOLOGY 4590 4590 4590 4590 4590 4590 4590 4590
CM0103-i-e : Cisplatin + capecitabine MEDICAL ONCOLOGY 2450 2450 2450 2450 2450 2450 2450 2450
CM0103-i-f : Fluorouracil & Oxaliplatin MEDICAL ONCOLOGY 25750 25750 25750 25750 25750 25750 25750 25750
CM0103-i-g : Oxaliplatin + capecitabine MEDICAL ONCOLOGY 8880 8880 8880 8880 8880 8880 8880 8880
CM0103-i-h : Irinotecan & Cisplatin MEDICAL ONCOLOGY 9676 9676 9676 9676 9676 9676 9676 9676
CM0103-i-i : Fluorouracil & Paclitaxel MEDICAL ONCOLOGY 5500 5500 5500 5500 5500 5500 5500 5500
CM0103-i-j : Paclitaxel + capecitabine MEDICAL ONCOLOGY 12200 12200 12200 12200 12200 12200 12200 12200
CM0103-i-k : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0103-ii : ESOPHAGEAL CANCER - Peri-Operative MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0103-ii-a : ECF (Epirubicin/Cisplatin/Fluorouracil) MEDICAL ONCOLOGY 16630 16630 16630 16630 16630 16630 16630 16630
CM0103-ii-b : EOF (Epirubicin/Cisplatin/Fluorouracil) MEDICAL ONCOLOGY 18610 18610 18610 18610 18610 18610 18610 18610
CM0103-ii-c : EOC (Epirubicin/Cisplatin/Fluorouracil) MEDICAL ONCOLOGY 7788 7788 7788 7788 7788 7788 7788 7788
CM0103-ii-d : Fluorouracil & Cisplatin MEDICAL ONCOLOGY 11980 11980 11980 11980 11980 11980 11980 11980
CM0103-ii-e : Fluorouracil & Cisplatin MEDICAL ONCOLOGY 7050 7050 7050 7050 7050 7050 7050 7050
CM0103-ii-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0103-iii : ESOPHAGEAL CANCER - Post-Operative MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0103-iii-a : Fluorouracil + Leucovorin (i) MEDICAL ONCOLOGY 25400 25400 25400 25400 25400 25400 25400 25400
CM0103-iii-b : Fluorouracil + Leucovorin (ii) MEDICAL ONCOLOGY 8980 8980 8980 8980 8980 8980 8980 8980
CM0103-iii-c : Capecitabine (i) MEDICAL ONCOLOGY 3016 3016 3016 3016 3016 3016 3016 3016
CM0103-iii-d : Capecitabine (ii) MEDICAL ONCOLOGY 1508 1508 1508 1508 1508 1508 1508 1508
CM0103-iii-e : Fluorouracil MEDICAL ONCOLOGY 6420 6420 6420 6420 6420 6420 6420 6420
CM0103-iii-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0103-iv : ESOPHAGEAL CANCER - Definitive MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0103-iv-a : Fluorouracil & Cisplatin (i) MEDICAL ONCOLOGY 11980 11980 11980 11980 11980 11980 11980 11980
CM0103-iv-b : Fluorouracil & Cisplatin (ii) MEDICAL ONCOLOGY 7050 7050 7050 7050 7050 7050 7050 7050
CM0103-iv-c : Fluorouracil & Oxaliplatin MEDICAL ONCOLOGY 25750 25750 25750 25750 25750 25750 25750 25750
CM0103-iv-d : Cisplatin + capecitabine MEDICAL ONCOLOGY 1950 1950 1950 1950 1950 1950 1950 1950
CM0103-iv-e : Oxaliplatin + capecitabine MEDICAL ONCOLOGY 8880 8880 8880 8880 8880 8880 8880 8880
CM0103-iv-f : Paclitaxel + Carboplatin MEDICAL ONCOLOGY 3230 3230 3230 3230 3230 3230 3230 3230
CM0103-iv-g : Cisplatin with Docetaxel (i) MEDICAL ONCOLOGY 8830 8830 8830 8830 8830 8830 8830 8830
CM0103-iv-h : Cisplatin with Docetaxel (ii) MEDICAL ONCOLOGY 2934 2934 2934 2934 2934 2934 2934 2934
CM0103-iv-i : Cisplatin with Paclitaxel MEDICAL ONCOLOGY 13100 13100 13100 13100 13100 13100 13100 13100
CM0103-iv-j : Irinotecan & Cisplatin MEDICAL ONCOLOGY 9676 9676 9676 9676 9676 9676 9676 9676
CM0103-iv-k : Fluorouracil & Paclitaxel MEDICAL ONCOLOGY 5500 5500 5500 5500 5500 5500 5500 5500
CM0103-iv-l : Paclitaxel + capecitabine MEDICAL ONCOLOGY 12200 12200 12200 12200 12200 12200 12200 12200
CM0103-iv-m : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0104 : GASTRIC CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0104-i : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0104-i-a : Paclitaxel + Carboplatin MEDICAL ONCOLOGY 3230 3230 3230 3230 3230 3230 3230 3230
CM0104-i-b : Fluorouracil & Cisplatin (i) MEDICAL ONCOLOGY 11980 11980 11980 11980 11980 11980 11980 11980
CM0104-i-c : Fluorouracil & Cisplatin (ii) MEDICAL ONCOLOGY 7050 7050 7050 7050 7050 7050 7050 7050
CM0104-i-d : Fluorouracil & Oxaliplatin (i) MEDICAL ONCOLOGY 25750 25750 25750 25750 25750 25750 25750 25750
CM0104-i-e : Fluorouracil & Oxaliplatin (ii) MEDICAL ONCOLOGY 6030 6030 6030 6030 6030 6030 6030 6030
CM0104-i-f : Cisplatin + capecitabine MEDICAL ONCOLOGY 1950 1950 1950 1950 1950 1950 1950 1950
CM0104-i-g : Oxaliplatin + capecitabine MEDICAL ONCOLOGY 8880 8880 8880 8880 8880 8880 8880 8880
CM0104-i-h : Fluorouracil & Paclitaxel MEDICAL ONCOLOGY 5500 5500 5500 5500 5500 5500 5500 5500
CM0104-i-i : Paclitaxel + capecitabine MEDICAL ONCOLOGY 3020 3020 3020 3020 3020 3020 3020 3020
CM0104-i-j : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0104-ii : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0104-ii-a : ECF (Epirubicin/Cisplatin/Fluorouracil) MEDICAL ONCOLOGY 16630 16630 16630 16630 16630 16630 16630 16630
CM0104-ii-b : EOF (Epirubicin/ oxaliplatin /Fluorouracil) MEDICAL ONCOLOGY 18610 18610 18610 18610 18610 18610 18610 18610
CM0104-ii-c : epirubicin + cisplatin + capecitabine MEDICAL ONCOLOGY 5808 5808 5808 5808 5808 5808 5808 5808
CM0104-ii-d : ECF modification: epirubicin + oxaliplatin + capecitabine MEDICAL ONCOLOGY 7788 7788 7788 7788 7788 7788 7788 7788
CM0104-ii-e : Fluorouracil & Cisplatin MEDICAL ONCOLOGY 6900 6900 6900 6900 6900 6900 6900 6900
CM0104-ii-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0104-iii : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction)1 MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0104-iii-a : Fluorouracil + Leucovorin (i) MEDICAL ONCOLOGY 25400 25400 25400 25400 25400 25400 25400 25400
CM0104-iii-b : Fluorouracil + Leucovorin (ii) MEDICAL ONCOLOGY 14900 14900 14900 14900 14900 14900 14900 14900
CM0104-iii-c : Capecitabine (i) MEDICAL ONCOLOGY 3016 3016 3016 3016 3016 3016 3016 3016
CM0104-iii-d : Capecitabine (ii) MEDICAL ONCOLOGY 1508 1508 1508 1508 1508 1508 1508 1508
CM0104-iii-e : Fluorouracil MEDICAL ONCOLOGY 6420 6420 6420 6420 6420 6420 6420 6420
CM0104-iii-f : Cisplatin + capecitabine MEDICAL ONCOLOGY 3966 3966 3966 3966 3966 3966 3966 3966
CM0104-iii-h : Oxaliplatin + capecitabine MEDICAL ONCOLOGY 5946 5946 5946 5946 5946 5946 5946 5946
CM0104-iii-i : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0105-i : COLORECTAL CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0105-i-a : FOLFOX (Stage - III) MEDICAL ONCOLOGY 6500 6500 6500 6500 6500 6500 6500 6500
CM0105-i-b : CAPEOX (Stage - III) MEDICAL ONCOLOGY 6450 6450 6450 6450 6450 6450 6450 6450
CM0105-i-c : FLOX (Stage - III) MEDICAL ONCOLOGY 29360 29360 29360 29360 29360 29360 29360 29360
CM0105-i-d : Capecitabine MEDICAL ONCOLOGY 4280 4280 4280 4280 4280 4280 4280 4280
CM0105-i-e : Fluorouracil + Leucovorin (i) MEDICAL ONCOLOGY 23660 23660 23660 23660 23660 23660 23660 23660
CM0105-i-f : Fluorouracil + Leucovorin (ii) MEDICAL ONCOLOGY 5180 5180 5180 5180 5180 5180 5180 5180
CM0105-i-g : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0105-ii : COLORECTAL CARCINOMA - Concurrent MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0105-ii-a : 5FU with XRT MEDICAL ONCOLOGY 3780 3780 3780 3780 3780 3780 3780 3780
CM0105-ii-b : Fluorouracil + Leucovorin with XRT MEDICAL ONCOLOGY 6100 6100 6100 6100 6100 6100 6100 6100
CM0105-ii-c : Capecitabine with XRT MEDICAL ONCOLOGY 1220 1220 1220 1220 1220 1220 1220 1220
CM0105-ii-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0106-106 : OSTEOSARCOMA/ BONE TUMORS MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0106-i-a : Cisplatin + doxorubicin MEDICAL ONCOLOGY 5525 5525 5525 5525 5525 5525 5525 5525
CM0106-i-b-1 : MAP (high-dose methotrexate + cisplatin + doxorubicin) PRE OPERATIVE MEDICAL ONCOLOGY 24185 24185 24185 24185 24185 24185 24185 24185
CM0106-i-b-2 : MAP (high-dose methotrexate + cisplatin + doxorubicin) POST OPERATIVE NECROSIS < 90% MEDICAL ONCOLOGY 40100 40100 40100 40100 40100 40100 40100 40100
CM0106-i-b-3 : MAP (high-dose methotrexate + cisplatin + doxorubicin) POST OPERATIVE NECROSIS > 90% MEDICAL ONCOLOGY 59025 59025 59025 59025 59025 59025 59025 59025
CM0106-i-c : Doxorubicin + cisplatin + ifosfamide + high-dose methotrexate (surgery to be done also) MEDICAL ONCOLOGY 111505 111505 111505 111505 111505 111505 111505 111505
CM0106-i-d : Ifosfamide + cisplatin + epirubicin MEDICAL ONCOLOGY 8288 8288 8288 8288 8288 8288 8288 8288
CM0106-ii : Other bone tumors 1) Chordroma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0106-ii-a : Imatinib MEDICAL ONCOLOGY 1550 1550 1550 1550 1550 1550 1550 1550
CM0106-ii-b : Imatinib + cisplatin MEDICAL ONCOLOGY 3675 3675 3675 3675 3675 3675 3675 3675
CM0106-ii-c : Imatinib + sirolimus MEDICAL ONCOLOGY 4269 4269 4269 4269 4269 4269 4269 4269
CM0106-ii-d : Erlotinib MEDICAL ONCOLOGY 2124 2124 2124 2124 2124 2124 2124 2124
CM0106-ii-e : Sunitinib MEDICAL ONCOLOGY 28500 28500 28500 28500 28500 28500 28500 28500
CM0106-iii : 2)Giant Cell Tumor of Bone MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0106-iii-a : Denosumab MEDICAL ONCOLOGY 56000 56000 56000 56000 56000 56000 56000 56000
CM0106-iii-b : Interferon alfa MEDICAL ONCOLOGY 4600 4600 4600 4600 4600 4600 4600 4600
CM0106-iii-c : Peginterferon MEDICAL ONCOLOGY 3500 3500 3500 3500 3500 3500 3500 3500
CM0106-iv : 3) Mesenchymal Chordosarcoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0106-iv-a : VAC and IE cycles MEDICAL ONCOLOGY 6420 6420 6420 6420 6420 6420 6420 6420
CM0106-iv-b : VAIA MEDICAL ONCOLOGY 7560 7560 7560 7560 7560 7560 7560 7560
CM0106-v : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0107 : WILMS TUMOR MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0107-a : Vincristine & Actinomycin D MEDICAL ONCOLOGY 19365 19365 19365 19365 19365 19365 19365 19365
CM0107-b : Dactinomycin, Vincristine & Adriamycin MEDICAL ONCOLOGY 23175 23175 23175 23175 23175 23175 23175 23175
CM0107-c : Adriamycin, Cyclophosphamide, Etoposide, Vincristine MEDICAL ONCOLOGY 53670 53670 53670 53670 53670 53670 53670 53670
CM0107-d : Cyclophosphamide, Etoposide, Carboplatin MEDICAL ONCOLOGY 84440 84440 84440 84440 84440 84440 84440 84440
CM0107-e : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0108 : HEPATOBLASTOMA- OPERABLE MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0108-a : PLADO - Cisplatin + Doxorubicin MEDICAL ONCOLOGY 2800 2800 2800 2800 2800 2800 2800 2800
CM0108-b : Cisplatin + Vincristine +5FU MEDICAL ONCOLOGY 2360 2360 2360 2360 2360 2360 2360 2360
CM0108-c : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0109 : HEPATOCELLULAR CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0109-a : Sorafenib MEDICAL ONCOLOGY 5800 5800 5800 5800 5800 5800 5800 5800
CM0109-b : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0110A : VINCRITINE/CISPLATIN/ETOPOSIDE/CYCLOPHOSPHAMIDE/CARBOPLATIN MEDICAL ONCOLOGY 7940 7940 7940 7940 7940 7940 7940 7940
CM0110B : CYCLOPHOSPHAMIDE/ADRIAMYCIN/VINCRISTINE MEDICAL ONCOLOGY 7050 7050 7050 7050 7050 7050 7050 7050
CM0110C : Cisplatin & Etoposide MEDICAL ONCOLOGY 4880 4880 4880 4880 4880 4880 4880 4880
CM0110D : Carboplatin & Etoposide MEDICAL ONCOLOGY 6430 6430 6430 6430 6430 6430 6430 6430
CM0110E : For Stage IV Palliative Chemotherapy only MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0110F : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0111 : RETINOBLASTOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0111-a : Melphalan - Intra-arterial MEDICAL ONCOLOGY 9700 9700 9700 9700 9700 9700 9700 9700
CM0111-b : Carboplatin - Intra-arterial MEDICAL ONCOLOGY 8890 8890 8890 8890 8890 8890 8890 8890
CM0111-c : Topotecan - Intra-arterial MEDICAL ONCOLOGY 9900 9900 9900 9900 9900 9900 9900 9900
CM0111-d : Methotrexate - Intra-arterial MEDICAL ONCOLOGY 8550 8550 8550 8550 8550 8550 8550 8550
CM0111-e : Carboplatin - Peri Ocular MEDICAL ONCOLOGY 1890 1890 1890 1890 1890 1890 1890 1890
CM0111-f : Topotecan - Peri Ocular MEDICAL ONCOLOGY 4300 4300 4300 4300 4300 4300 4300 4300
CM0111-g : Melphalan - Intra-vitreal MEDICAL ONCOLOGY 2700 2700 2700 2700 2700 2700 2700 2700
CM0111-h : Carboplatin - Intra-vitreal MEDICAL ONCOLOGY 1890 1890 1890 1890 1890 1890 1890 1890
CM0111-i : Methotrexate - Intra-vitreal MEDICAL ONCOLOGY 1550 1550 1550 1550 1550 1550 1550 1550
CM0111-j : Carboplatin + Etoposide + Vincristine MEDICAL ONCOLOGY 6800 6800 6800 6800 6800 6800 6800 6800
CM0111-k : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0112 : LANGERHANS CELL HISTIOCYTOSIS MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0112-a : Prednisolone and Vinblastine - 1 MEDICAL ONCOLOGY 6059 6059 6059 6059 6059 6059 6059 6059
CM0112-b : Prednisolone and Vinblastine - 2 MEDICAL ONCOLOGY 6734 6734 6734 6734 6734 6734 6734 6734
CM0112-c : Prednisolone and Vinblastine - continuation MEDICAL ONCOLOGY 1720 1720 1720 1720 1720 1720 1720 1720
CM0112-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0113 : RHABDOMYOSARCOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0113-a : VAC (Vincristine + Dactinomycin + Cyclophosphamide + Mesna ) MEDICAL ONCOLOGY 3755 3755 3755 3755 3755 3755 3755 3755
CM0113-b : IVA (Vincristine + Dactinomycin + Ifosfamide + Mesna ) MEDICAL ONCOLOGY 5551 5551 5551 5551 5551 5551 5551 5551
CM0113-c : IVAD (Vincristine + Doxorubicin + Ifosfamide + Mesna ) MEDICAL ONCOLOGY 5494 5494 5494 5494 5494 5494 5494 5494
CM0113-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0114 : EWINGS SARCOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0114-i : Induction Treatment I MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0114-i-a : VIDE MEDICAL ONCOLOGY 8235 8235 8235 8235 8235 8235 8235 8235
CM0114-i-b : VAC/IE MEDICAL ONCOLOGY 6390 6390 6390 6390 6390 6390 6390 6390
CM0114-i-c : VAIA - 4 day Regimen MEDICAL ONCOLOGY 7560 7560 7560 7560 7560 7560 7560 7560
CM0114-i-d : VAIA - 24 day Regimen MEDICAL ONCOLOGY 17660 17660 17660 17660 17660 17660 17660 17660
CM0114-ii : Maintenance Treatment MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0114-ii-a : Etoposide/Ifosfamide MEDICAL ONCOLOGY 8190 8190 8190 8190 8190 8190 8190 8190
CM0114-iii : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0115 : PALLIATIVE CHEMOTHERAPY (Any Regimen)- Maximum Payable MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0116 : CERVICAL CANCER MEDICAL ONCOLOGY 3300 3300 3300 3300 3300 3300 3300 3300
CM0116-a : CISPLATIN MEDICAL ONCOLOGY 3300 3300 3300 3300 3300 3300 3300 3300
CM0116-b : Cisplatin & 5FU with RT MEDICAL ONCOLOGY 9200 9200 9200 9200 9200 9200 9200 9200
CM0116-c : Cisplatin & 5FU MEDICAL ONCOLOGY 8900 8900 8900 8900 8900 8900 8900 8900
CM0116-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0117 : VULVAL CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0117-a : Cisplatin MEDICAL ONCOLOGY 1800 1800 1800 1800 1800 1800 1800 1800
CM0117-b : Cisplatin + 5FU MEDICAL ONCOLOGY 8620 8620 8620 8620 8620 8620 8620 8620
CM0117-c : 5-FU + Mitomycin MEDICAL ONCOLOGY 11360 11360 11360 11360 11360 11360 11360 11360
CM0117-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0118 : VAGINAL CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0118-a : Cisplatin MEDICAL ONCOLOGY 1800 1800 1800 1800 1800 1800 1800 1800
CM0118-b : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0119 : OVARIAN CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0119-a : Paclitaxel + Cisplatin MEDICAL ONCOLOGY 8750 8750 8750 8750 8750 8750 8750 8750
CM0119-b : Paclitaxel + Carboplatin MEDICAL ONCOLOGY 7000 7000 7000 7000 7000 7000 7000 7000
CM0119-c : Docetaxel + Carboplatin MEDICAL ONCOLOGY 8700 8700 8700 8700 8700 8700 8700 8700
CM0119-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0120 : ENDOMETRIAL CANCER (Palliative Chemotherapy only) MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0121 : OVARY- GERM CELL TUMOR MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0121-a : BEP (Bleomycin + Etoposide + Cisplatin) MEDICAL ONCOLOGY 10780 10780 10780 10780 10780 10780 10780 10780
CM0121-b : EP ( Etoposide + Carboplatin) MEDICAL ONCOLOGY 6430 6430 6430 6430 6430 6430 6430 6430
CM0121-c : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0122 : GESTATIONAL TROPHOBLAST DISEASES MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0122-a : Methotrexate (5 days regimen) MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0122-b : Methotrexate (8-day alternating regimen) MEDICAL ONCOLOGY 2860 2860 2860 2860 2860 2860 2860 2860
CM0122-c : Methotrexate + Folinic Acid MEDICAL ONCOLOGY 1980 1980 1980 1980 1980 1980 1980 1980
CM0122-d : Methotrexate - Weekly MEDICAL ONCOLOGY 1300 1300 1300 1300 1300 1300 1300 1300
CM0122-e : Act-D MEDICAL ONCOLOGY 7800 7800 7800 7800 7800 7800 7800 7800
CM0122-f : Actinomycin MEDICAL ONCOLOGY 2190 2190 2190 2190 2190 2190 2190 2190
CM0122-g : EMA-CO (complete) MEDICAL ONCOLOGY 6360 6360 6360 6360 6360 6360 6360 6360
CM0122-h : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0123 : TESTICULAR CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0123-a : EP MEDICAL ONCOLOGY 5360 5360 5360 5360 5360 5360 5360 5360
CM0123-b : BEP MEDICAL ONCOLOGY 9980 9980 9980 9980 9980 9980 9980 9980
CM0123-c : VIP MEDICAL ONCOLOGY 6250 6250 6250 6250 6250 6250 6250 6250
CM0123-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0124 : PROSTATE CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0124-a : Docetaxel + prednisone MEDICAL ONCOLOGY 3515 3515 3515 3515 3515 3515 3515 3515
CM0124-b : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0125 : FEBRILE NEUTROPENIA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0125-a : First-line monotherapy MEDICAL ONCOLOGY 13500 13500 13500 13500 13500 13500 13500 13500
CM0125-b : Second-line dual therapy MEDICAL ONCOLOGY 19500 19500 19500 19500 19500 19500 19500 19500
CM0125-c : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0126 : THYROID CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0126-a : sorafenib MEDICAL ONCOLOGY 2900 2900 2900 2900 2900 2900 2900 2900
CM0126-b : sunitinib MEDICAL ONCOLOGY 28500 28500 28500 28500 28500 28500 28500 28500
CM0126-c : Small molecule kinase inhibitor MEDICAL ONCOLOGY 9500 9500 9500 9500 9500 9500 9500 9500
CM0126-d : Doxorubicin MEDICAL ONCOLOGY 4350 4350 4350 4350 4350 4350 4350 4350
CM0126-e : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0127 : THYMOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0127-a : CAP MEDICAL ONCOLOGY 4600 4600 4600 4600 4600 4600 4600 4600
CM0127-b : CAPP MEDICAL ONCOLOGY 6771 6771 6771 6771 6771 6771 6771 6771
CM0127-c : ADOC MEDICAL ONCOLOGY 2870 2870 2870 2870 2870 2870 2870 2870
CM0127-d : PE MEDICAL ONCOLOGY 5080 5080 5080 5080 5080 5080 5080 5080
CM0127-e : VIP MEDICAL ONCOLOGY 7600 7600 7600 7600 7600 7600 7600 7600
CM0127-f : Carboplatin+paclitaxel MEDICAL ONCOLOGY 9300 9300 9300 9300 9300 9300 9300 9300
CM0127-g : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0128 : BRAIN CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-i : Systemic Therapy for Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-i-a : Combination PCV (lomustine + procarbazine + vincristine) MEDICAL ONCOLOGY 3800 3800 3800 3800 3800 3800 3800 3800
CM0128-i-b : Temozolomide (7 weeks) MEDICAL ONCOLOGY 6500 6500 6500 6500 6500 6500 6500 6500
CM0128-i-c : Temozolomide monthly 5-day course MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0128-i-d : Temozolomide (3 weeks) MEDICAL ONCOLOGY 3310 3310 3310 3310 3310 3310 3310 3310
CM0128-ii : Systemic Therapy for Anaplastic Gliomas MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-ii-a : Temozolomide monthly 5-day course MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0128-ii-b : PCV with deferred RT (lomustine + procarbazine + vincristine) MEDICAL ONCOLOGY 3800 3800 3800 3800 3800 3800 3800 3800
CM0128-ii-c : Concurrent Temozolomide (with RT) - followed by adjuvant temozolomide MEDICAL ONCOLOGY 14230 14230 14230 14230 14230 14230 14230 14230
CM0128-ii-d : Adjuvant Temozolomide MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0128-ii-e : PCV for 1p19q co-deleted (with Radiotherapy) MEDICAL ONCOLOGY 3800 3800 3800 3800 3800 3800 3800 3800
CM0128-iii : Systemic Therapy for Glioblastoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-iii-a : Concurrent Temozolomide (with RT) - followed by adjuvant temozolomide MEDICAL ONCOLOGY 14230 14230 14230 14230 14230 14230 14230 14230
CM0128-iii-b : Adjuvant Temozolomide MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0128-iii-c : Temozolomide (post RT) MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0128-iii-d : Temozolomide (200mg) with standard RT MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0128-iv : Systemic Therapy for Adult Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor (PNET) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-iv-a : Vincristine + cisplatin + lomustine MEDICAL ONCOLOGY 4320 4320 4320 4320 4320 4320 4320 4320
CM0128-iv-b : Vincristine + cisplatin + cyclophosphamide MEDICAL ONCOLOGY 5480 5480 5480 5480 5480 5480 5480 5480
CM0128-v : Primary CNS Lymphoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-v-a : High dose methotrexate combined with the following plus radiation therapy MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-v-a-1 : High dose Methotrexate + Cytarabine MEDICAL ONCOLOGY 6520 6520 6520 6520 6520 6520 6520 6520
CM0128-v-a-2 : High dose Methotrexate + leucovorin + Ifosfamide + mesna MEDICAL ONCOLOGY 9405 9405 9405 9405 9405 9405 9405 9405
CM0128-v-b : High dose methotrexate combined with the following plus radiation therapy MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-v-b-1 : Rituximab + MTX + vincristine +procarbazine MEDICAL ONCOLOGY 41890 41890 41890 41890 41890 41890 41890 41890
CM0128-v-c : High dose methotrexate (MTX 8.0mg/m2) + chemotherapy with or without monoclonal antibody MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-v-c-1 : High dose methotrexate Induction MEDICAL ONCOLOGY 8900 8900 8900 8900 8900 8900 8900 8900
CM0128-v-c-2 : High dose methotrexate Consolidation MEDICAL ONCOLOGY 2700 2700 2700 2700 2700 2700 2700 2700
CM0128-v-c-3-i : High dose methotrexate Maintanance 1-4 cycles MEDICAL ONCOLOGY 25530 25530 25530 25530 25530 25530 25530 25530
CM0128-v-c-3-ii : High dose methotrexate Maintanance 5-11 cycles MEDICAL ONCOLOGY 1550 1550 1550 1550 1550 1550 1550 1550
CM0128-v-d : Rituximab + Temozolomide regimen MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-v-d-1 : Rituximab + Temozolomide regimen - Induction MEDICAL ONCOLOGY 26580 26580 26580 26580 26580 26580 26580 26580
CM0128-v-d-2 : Rituximab + Temozolomide regimen - Maintanance MEDICAL ONCOLOGY 1600 1600 1600 1600 1600 1600 1600 1600
CM0128-v-e : Meningioma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0128-v-e-1 : Interferon-alfa MEDICAL ONCOLOGY 6000 6000 6000 6000 6000 6000 6000 6000
CM0128-v-e-2 : Somatostatin analog MEDICAL ONCOLOGY 5400 5400 5400 5400 5400 5400 5400 5400
CM0128-v-e-3 : Sunitinib MEDICAL ONCOLOGY 29000 29000 29000 29000 29000 29000 29000 29000
CM0129 : HEAD AND NECK CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0129-i : Squamous Cell Cancers MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0129-i-a : HIgh Dose Cisplatin MEDICAL ONCOLOGY 5250 5250 5250 5250 5250 5250 5250 5250
CM0129-i-b : Carboplatin + infusional 5-FU MEDICAL ONCOLOGY 4760 4760 4760 4760 4760 4760 4760 4760
CM0129-i-c : 5-FU + hydroxyurea MEDICAL ONCOLOGY 2220 2220 2220 2220 2220 2220 2220 2220
CM0129-i-d : Cisplatin + paclitaxel MEDICAL ONCOLOGY 3350 3350 3350 3350 3350 3350 3350 3350
CM0129-i-e : Cisplatin + infusional 5-FU MEDICAL ONCOLOGY 5250 5250 5250 5250 5250 5250 5250 5250
CM0129-i-f : Carboplatin + paclitaxel MEDICAL ONCOLOGY 3480 3480 3480 3480 3480 3480 3480 3480
CM0129-i-g : Weekly cisplatin MEDICAL ONCOLOGY 4700 4700 4700 4700 4700 4700 4700 4700
CM0129-i-h : Cisplatin (For high risk oropharyngeal carcinoma) MEDICAL ONCOLOGY 5250 5250 5250 5250 5250 5250 5250 5250
CM0129-i-i : Docetaxel + cisplatin + 5-FU MEDICAL ONCOLOGY 6620 6620 6620 6620 6620 6620 6620 6620
CM0129-i-j : Paclitaxel + cisplatin+ infusional 5-FU MEDICAL ONCOLOGY 7850 7850 7850 7850 7850 7850 7850 7850
CM0129-ii : Nasopharynx Cancer MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0129-ii-a : Concurrent Cisplatin followed by concurrent Cisplatin +5FU MEDICAL ONCOLOGY 8450 8450 8450 8450 8450 8450 8450 8450
CM0129-ii-a-1 : Concurrent Cisplatin (followed by concurrent Cisplatin +5FU) MEDICAL ONCOLOGY 1250 1250 1250 1250 1250 1250 1250 1250
CM0129-ii-a-2 : concurrent Cisplatin +5FU Preceeded by (Concurrent Cisplatin ) MEDICAL ONCOLOGY 4800 4800 4800 4800 4800 4800 4800 4800
CM0129-ii-b : Concurrent Carboplatin followed by concurrent Carboplatin +5FU MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0129-ii-b-1 : Concurrent Carboplatin (followed by concurrent Carboplatin +5FU) MEDICAL ONCOLOGY 3800 3800 3800 3800 3800 3800 3800 3800
CM0129-ii-b-2 : concurrent Carboplatin +5FU Preceeded by (Concurrent Carboplatin ) MEDICAL ONCOLOGY 13900 13900 13900 13900 13900 13900 13900 13900
CM0129-ii-c : Concurrent Cisplatin MEDICAL ONCOLOGY 2300 2300 2300 2300 2300 2300 2300 2300
CM0129-ii-d : Docetaxel + cisplatin + 5-FU MEDICAL ONCOLOGY 6620 6620 6620 6620 6620 6620 6620 6620
CM0129-ii-d-1 : Docetaxel + cisplatin + 5-FU followed by Cisplatin after 3 cycles MEDICAL ONCOLOGY 6370 6370 6370 6370 6370 6370 6370 6370
CM0129-ii-d-2 : Cisplatin - weekly Preceded by 3 cycles of Docetaxel + 5-FU MEDICAL ONCOLOGY 2250 2250 2250 2250 2250 2250 2250 2250
CM0129-ii-e : Docetaxel + cisplatin MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0129-ii-e-1 : Docetaxel + cisplatin followed by Cisplatin after 2 cycles MEDICAL ONCOLOGY 3320 3320 3320 3320 3320 3320 3320 3320
CM0129-ii-e-2 : Cisplatin - weekly Preceded by 2 cycles of Docetaxel + cisplatin MEDICAL ONCOLOGY 1800 1800 1800 1800 1800 1800 1800 1800
CM0129-ii-f : Cisplatin + 5-FU MEDICAL ONCOLOGY 5050 5050 5050 5050 5050 5050 5050 5050
CM0129-iii : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0130 : RENAL CELL CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0130-a : Pazopanib MEDICAL ONCOLOGY 19000 19000 19000 19000 19000 19000 19000 19000
CM0130-b : Sunitinib MEDICAL ONCOLOGY 29000 29000 29000 29000 29000 29000 29000 29000
CM0130-c : Sorafenib MEDICAL ONCOLOGY 5800 5800 5800 5800 5800 5800 5800 5800
CM0130-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0131 : UNKNOWN PRIMARY MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0131-i : Adenocarcinoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0131-i-a : Paclitaxel + carboplatin + etoposide MEDICAL ONCOLOGY 7950 7950 7950 7950 7950 7950 7950 7950
CM0131-i-b : Paclitaxel + carboplatin MEDICAL ONCOLOGY 7200 7200 7200 7200 7200 7200 7200 7200
CM0131-i-c : Docetaxel + carboplatin MEDICAL ONCOLOGY 3800 3800 3800 3800 3800 3800 3800 3800
CM0131-i-d : Gemcitabine + cisplatin MEDICAL ONCOLOGY 5250 5250 5250 5250 5250 5250 5250 5250
CM0131-i-e : Gemcitabine + docetaxel MEDICAL ONCOLOGY 5720 5720 5720 5720 5720 5720 5720 5720
CM0131-i-f : Gemcitabine + irinotecan MEDICAL ONCOLOGY 5560 5560 5560 5560 5560 5560 5560 5560
CM0131-ii : Squamous cell carcinoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0131-ii-a : Paclitaxel + cisplatin + 5-FU MEDICAL ONCOLOGY 6170 6170 6170 6170 6170 6170 6170 6170
CM0131-ii-b : Docetaxel + cisplatin + 5-FU MEDICAL ONCOLOGY 6770 6770 6770 6770 6770 6770 6770 6770
CM0131-iii : Neuroendocrine tumors MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0131-iii-b : Etoposide + cisplatin MEDICAL ONCOLOGY 4980 4980 4980 4980 4980 4980 4980 4980
CM0131-iv : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0132 : CA HEPATO BILIARY /CA COMMON BILE DUCT/CA GALLBLADDER/ CHOLANGIOCARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0132-a : Gemcitabine + cisplatin MEDICAL ONCOLOGY 3697 3697 3697 3697 3697 3697 3697 3697
CM0132-b : 5-FU MEDICAL ONCOLOGY 4100 4100 4100 4100 4100 4100 4100 4100
CM0132-c : Capecitabine MEDICAL ONCOLOGY 3520 3520 3520 3520 3520 3520 3520 3520
CM0132-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0133 : PANCREAS CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0133-i : Patients with resectable pancreatic cancer: Locally Advanced MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0133-i-a : Gemcitabine MEDICAL ONCOLOGY 6515 6515 6515 6515 6515 6515 6515 6515
CM0133-ii : Adjuvant chemotherapy and chemoradiation: MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0133-ii-a : 5-FU + Leucovorin MEDICAL ONCOLOGY 5000 5000 5000 5000 5000 5000 5000 5000
CM0133-ii-b : Gemcitabine & 5FU MEDICAL ONCOLOGY 6695 6695 6695 6695 6695 6695 6695 6695
CM0133-ii-c : Continuous infusion 5-FU (with Radiation) MEDICAL ONCOLOGY 20620 20620 20620 20620 20620 20620 20620 20620
CM0133-iii : Neoadjuvant therapy: MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0133-iii-a : Capecitabine MEDICAL ONCOLOGY 3520 3520 3520 3520 3520 3520 3520 3520
CM0133-iv : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0134 : PERI AMPULLARY CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0134-a : 5-FU MEDICAL ONCOLOGY 5300 5300 5300 5300 5300 5300 5300 5300
CM0134-b : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0135 : NEURO ENDOCRINE CARCINOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0135-a : All NECs are covered under Organ Cancers. If uncovered Unlisted only. MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0135-b : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0136 : SARCOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0136-i : Gastrointestinal Stromal Tumor - GIST MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0136-i-a : Imatinib MEDICAL ONCOLOGY 1525 1525 1525 1525 1525 1525 1525 1525
CM0136-ii : SOFT TISSUE SARCOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0136-ii-a : Doxorubicin + dacarbazine (AD) MEDICAL ONCOLOGY 11420 11420 11420 11420 11420 11420 11420 11420
CM0136-ii-b : Doxorubicin + ifosfamide + mesna MEDICAL ONCOLOGY 9166 9166 9166 9166 9166 9166 9166 9166
CM0136-ii-c : Mesna + doxorubicin + ifosfamide + dacarbazine (MAID) MEDICAL ONCOLOGY 10700 10700 10700 10700 10700 10700 10700 10700
CM0136-ii-d : Ifosfamide + epirubicin + mesna MEDICAL ONCOLOGY 12770 12770 12770 12770 12770 12770 12770 12770
CM0136-ii-e : Gemcitabine + docetaxel MEDICAL ONCOLOGY 5060 5060 5060 5060 5060 5060 5060 5060
CM0136-ii-f : Gemcitabine + vinorelbine MEDICAL ONCOLOGY 14640 14640 14640 14640 14640 14640 14640 14640
CM0136-ii-g : Gemcitabine + dacarbazine MEDICAL ONCOLOGY 3255 3255 3255 3255 3255 3255 3255 3255
CM0136-ii-h : Doxorubicin MEDICAL ONCOLOGY 2900 2900 2900 2900 2900 2900 2900 2900
CM0136-ii-i : Ifosfamide MEDICAL ONCOLOGY 9956 9956 9956 9956 9956 9956 9956 9956
CM0136-ii-j : Ifosfamide MEDICAL ONCOLOGY 4855 4855 4855 4855 4855 4855 4855 4855
CM0136-ii-k : Epirubicin MEDICAL ONCOLOGY 5900 5900 5900 5900 5900 5900 5900 5900
CM0136-ii-l : Gemcitabine MEDICAL ONCOLOGY 3505 3505 3505 3505 3505 3505 3505 3505
CM0136-ii-m : Dacarbazine (i) MEDICAL ONCOLOGY 6175 6175 6175 6175 6175 6175 6175 6175
CM0136-ii-n : Dacarbazine (ii) MEDICAL ONCOLOGY 2350 2350 2350 2350 2350 2350 2350 2350
CM0136-ii-o : Liposomal doxorubicin MEDICAL ONCOLOGY 7860 7860 7860 7860 7860 7860 7860 7860
CM0136-ii-p : Temozolomide MEDICAL ONCOLOGY 4190 4190 4190 4190 4190 4190 4190 4190
CM0136-iii : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0137 : PRIMITIVE NEURO ECTODERMAL TUMOR MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0137-a : Weekly vincristine MEDICAL ONCOLOGY 1640 1640 1640 1640 1640 1640 1640 1640
CM0137-b : Vincristine + cisplatin + lomustine MEDICAL ONCOLOGY 4360 4360 4360 4360 4360 4360 4360 4360
CM0137-c : Vincristine + cisplatin + cyclophosphamide MEDICAL ONCOLOGY 7570 7570 7570 7570 7570 7570 7570 7570
CM0137-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0137-vi : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0138 : MELANOMA - No primary regimens only RT. For advanced unresectable and metastatic disease - Pallitive Chemotherapy (Maximum) MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0139 : ANAL CANAL CANCER MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0139-a : 5-FU + Mitomycin MEDICAL ONCOLOGY 11360 11360 11360 11360 11360 11360 11360 11360
CM0139-b : Capecitabine + Mitomycin (i) MEDICAL ONCOLOGY 8080 8080 8080 8080 8080 8080 8080 8080
CM0139-c : Capecitabine + Mitomycin (ii) MEDICAL ONCOLOGY 6765 6765 6765 6765 6765 6765 6765 6765
CM0139-d : Cisplatin + 5-FU MEDICAL ONCOLOGY 6650 6650 6650 6650 6650 6650 6650 6650
CM0139-e : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952 : SURGERY/CHEMOTHERAPY/RADIOTHERAPY FOR ALL LEUKEMIAS MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A : All Leukemia ( Chemotheraphy) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-I : Chronic Myeloid Leukemia (CML) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-I-i-a : Imatinib MEDICAL ONCOLOGY 1525 1525 1525 1525 1525 1525 1525 1525
CM0952A-I-i-b : Nilotinib MEDICAL ONCOLOGY 17800 17800 17800 17800 17800 17800 17800 17800
CM0952A-I-ii : Blast phase-Lymphoid ALL Type Induction + TKI MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-I-ii-a : Induction MEDICAL ONCOLOGY 12840 12840 12840 12840 12840 12840 12840 12840
CM0952A-I-ii-b : Imatinib MEDICAL ONCOLOGY 1525 1525 1525 1525 1525 1525 1525 1525
CM0952A-I-ii-c : Nilotinib MEDICAL ONCOLOGY 17800 17800 17800 17800 17800 17800 17800 17800
CM0952A-I-iii : Blast phase-myeloid AML Type Induction + TKI MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-I-iii-a : Daunorubicin (90mg/m2)+ Cytarabine MEDICAL ONCOLOGY 12320 12320 12320 12320 12320 12320 12320 12320
CM0952A-I-iii-b : Daunorubicin + Cytarabine + Cladribine MEDICAL ONCOLOGY 10365 10365 10365 10365 10365 10365 10365 10365
CM0952A-I-iii-c : Daunorubicin + Cytarabine (High Dose) MEDICAL ONCOLOGY 16725 16725 16725 16725 16725 16725 16725 16725
CM0952A-I-iii-d : Daunorubicin (90mg) + Cytarabine MEDICAL ONCOLOGY 12320 12320 12320 12320 12320 12320 12320 12320
CM0952A-I-iii-e : Idarubicin + Cytarabine (High Dose) MEDICAL ONCOLOGY 29600 29600 29600 29600 29600 29600 29600 29600
CM0952A-I-iii-f : Idarubicin + Cytarabine MEDICAL ONCOLOGY 23240 23240 23240 23240 23240 23240 23240 23240
CM0952A-I-iii-g : mitoxantrone + Cytarabine MEDICAL ONCOLOGY 10820 10820 10820 10820 10820 10820 10820 10820
CM0952A-I-iii-h : Imatinib MEDICAL ONCOLOGY 1525 1525 1525 1525 1525 1525 1525 1525
CM0952A-I-iii-i : Nilotinib MEDICAL ONCOLOGY 17800 17800 17800 17800 17800 17800 17800 17800
CM0952A-I-iii-ii : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-I-iii-iii : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-II : Acute Myeloid Leukemia (AML) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-II-a : Daunorubicin + Cytarabine 1 MEDICAL ONCOLOGY 12320 12320 12320 12320 12320 12320 12320 12320
CM0952A-II-b : Idarubicin + Cytarabine MEDICAL ONCOLOGY 23240 23240 23240 23240 23240 23240 23240 23240
CM0952A-II-c : Daunorubicin + Cytarabine 2 MEDICAL ONCOLOGY 10365 10365 10365 10365 10365 10365 10365 10365
CM0952A-II-d : Daunorubicin + Cytarabine (High Dose) MEDICAL ONCOLOGY 16725 16725 16725 16725 16725 16725 16725 16725
CM0952A-II-e : Idarubicin + Cytarabine (High Dose) MEDICAL ONCOLOGY 29600 29600 29600 29600 29600 29600 29600 29600
CM0952A-II-f : Daunorubicin (90mg) + Cytarabine MEDICAL ONCOLOGY 12320 12320 12320 12320 12320 12320 12320 12320
CM0952A-II-g : idarubicin + Cytarabine MEDICAL ONCOLOGY 23240 23240 23240 23240 23240 23240 23240 23240
CM0952A-II-h : mitoxantrone + Cytarabine MEDICAL ONCOLOGY 10280 10280 10280 10280 10280 10280 10280 10280
CM0952A-II-i : Cytarabine MEDICAL ONCOLOGY 6800 6800 6800 6800 6800 6800 6800 6800
CM0952A-II-j : Decitabine MEDICAL ONCOLOGY 25000 25000 25000 25000 25000 25000 25000 25000
CM0952A-II-k : azacytidine MEDICAL ONCOLOGY 77500 77500 77500 77500 77500 77500 77500 77500
CM0952A-II-l : Hydroxyurea MEDICAL ONCOLOGY 1600 1600 1600 1600 1600 1600 1600 1600
CM0952A-II-m : Cytarabine - High Dose MEDICAL ONCOLOGY 9720 9720 9720 9720 9720 9720 9720 9720
CM0952A-II-n : Cladribine + Cytarabine + Idarubicin + Gcsf MEDICAL ONCOLOGY 85150 85150 85150 85150 85150 85150 85150 85150
CM0952A-II-o : Cladribine + Cytarabine + Mitoxantrone + Gcsf MEDICAL ONCOLOGY 40690 40690 40690 40690 40690 40690 40690 40690
CM0952A-II-p : Fludarabine + Cytarabine + Idarubicin + Gcsf MEDICAL ONCOLOGY 66710 66710 66710 66710 66710 66710 66710 66710
CM0952A-II-q : Etoposide +Cytarabine+Mitoxantrone MEDICAL ONCOLOGY 13260 13260 13260 13260 13260 13260 13260 13260
CM0952A-II-r : Cytarabine SC MEDICAL ONCOLOGY 2800 2800 2800 2800 2800 2800 2800 2800
CM0952A-II-s : azacytidine MEDICAL ONCOLOGY 77500 77500 77500 77500 77500 77500 77500 77500
CM0952A-II-t : Decitabine MEDICAL ONCOLOGY 25500 25500 25500 25500 25500 25500 25500 25500
CM0952A-II-u : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-III : Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL / SLL) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-III-a-i : Rituximab + chlorambucil Cycle 1 MEDICAL ONCOLOGY 1084 1084 1084 1084 1084 1084 1084 1084
CM0952A-III-a-ii : Rituximab + chlorambucil Cycle 3 MEDICAL ONCOLOGY 25584 25584 25584 25584 25584 25584 25584 25584
CM0952A-III-a-iii : Rituximab + chlorambucil Cycle 4-8 MEDICAL ONCOLOGY 32984 32984 32984 32984 32984 32984 32984 32984
CM0952A-III-a-iv : Maintanance - Rituximab MEDICAL ONCOLOGY 25500 25500 25500 25500 25500 25500 25500 25500
CM0952A-III-b : Rituximab Day 1, 8, 15, and 22: MEDICAL ONCOLOGY 100500 100500 100500 100500 100500 100500 100500 100500
CM0952A-III-c : Chlorambucil MEDICAL ONCOLOGY 2344 2344 2344 2344 2344 2344 2344 2344
CM0952A-III-d-i : Bendamustine + Rituximab (Cycle -1) MEDICAL ONCOLOGY 36500 36500 36500 36500 36500 36500 36500 36500
CM0952A-III-d-ii : Bendamustine + Rituximab (Cycles 2-6) MEDICAL ONCOLOGY 37900 37900 37900 37900 37900 37900 37900 37900
CM0952A-III-d-iii : Bendamustine (70mg) (Cycle -1) MEDICAL ONCOLOGY 12500 12500 12500 12500 12500 12500 12500 12500
CM0952A-III-d-iv : Bendamustine (90 mg) (Cycles 2-6) MEDICAL ONCOLOGY 6500 6500 6500 6500 6500 6500 6500 6500
CM0952A-III-e : Fludarabine + cyclophosphamide + rituximab (FCR) MEDICAL ONCOLOGY 31898 31898 31898 31898 31898 31898 31898 31898
CM0952A-III-f : Fludarabine + rituximab (FR) MEDICAL ONCOLOGY 67930 67930 67930 67930 67930 67930 67930 67930
CM0952A-III-g : Alemtuzumab + rituximab MEDICAL ONCOLOGY 108950 108950 108950 108950 108950 108950 108950 108950
CM0952A-III-h : Alemtuzumab without rituximab MEDICAL ONCOLOGY 11450 11450 11450 11450 11450 11450 11450 11450
CM0952A-III-i : High-dose methylprednisolone + rituximab MEDICAL ONCOLOGY 103955 103955 103955 103955 103955 103955 103955 103955
CM0952A-III-j : High-dose methylprednisolone MEDICAL ONCOLOGY 6455 6455 6455 6455 6455 6455 6455 6455
CM0952A-III-k : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-IV : Acute Lymphoblastic Leukemia (ALL) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-IV-i : Ph(+) AYA (Age 15-39 years) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-IV-i-a-1 : Childrens Oncology Group (COG) AALL-0031 INDUCTION PHASE MEDICAL ONCOLOGY 13340 13340 13340 13340 13340 13340 13340 13340
CM0952A-IV-i-a-2 : Childrens Oncology Group (COG) AALL-0031 CONSOLIDATION PHASE - BLOCK 1 MEDICAL ONCOLOGY 17095 17095 17095 17095 17095 17095 17095 17095
CM0952A-IV-i-a-3 : Childrens Oncology Group (COG) AALL-0031 CONSOLIDATION PHASE - BLOCK 2 MEDICAL ONCOLOGY 19175 19175 19175 19175 19175 19175 19175 19175
CM0952A-IV-i-a-4 : Childrens Oncology Group (COG) AALL-0031 REINDUCTION MEDICAL ONCOLOGY 25291 25291 25291 25291 25291 25291 25291 25291
CM0952A-IV-i-a-5 : Childrens Oncology Group (COG) AALL-0031 INTENSIFICATION MEDICAL ONCOLOGY 41425 41425 41425 41425 41425 41425 41425 41425
CM0952A-IV-i-a-6 : Childrens Oncology Group (COG) AALL-0031 MAINTENANCE Cycles 1-4 (8 weeks) MEDICAL ONCOLOGY 35621 35621 35621 35621 35621 35621 35621 35621
CM0952A-IV-i-a-7 : Childrens Oncology Group (COG) AALL-0031 MAINTENANCE Cycles 5-12 (8 weeks) MEDICAL ONCOLOGY 12836 12836 12836 12836 12836 12836 12836 12836
CM0952A-IV-i-b-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3) MEDICAL ONCOLOGY 59429 59429 59429 59429 59429 59429 59429 59429
CM0952A-IV-i-b-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4) MEDICAL ONCOLOGY 62380 62380 62380 62380 62380 62380 62380 62380
CM0952A-IV-i-b-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7) MEDICAL ONCOLOGY 11469 11469 11469 11469 11469 11469 11469 11469
CM0952A-IV-i-b-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8) MEDICAL ONCOLOGY 13420 13420 13420 13420 13420 13420 13420 13420
CM0952A-IV-i-b-5 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction II MEDICAL ONCOLOGY 15133 15133 15133 15133 15133 15133 15133 15133
CM0952A-IV-i-b-6 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction III MEDICAL ONCOLOGY 5535 5535 5535 5535 5535 5535 5535 5535
CM0952A-IV-i-b-7 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Maintenance MEDICAL ONCOLOGY 9923 9923 9923 9923 9923 9923 9923 9923
CM0952A-IV-i-c-1 : Multiagent Chemotherapy + TKIs INDUCTION PHASE MEDICAL ONCOLOGY 15133 15133 15133 15133 15133 15133 15133 15133
CM0952A-IV-i-c-2 : Multiagent Chemotherapy + TKIs CONSOLIDATION I MEDICAL ONCOLOGY 8460 8460 8460 8460 8460 8460 8460 8460
CM0952A-IV-i-c-3 : Multiagent Chemotherapy + TKIs CONSOLIDATION II MEDICAL ONCOLOGY 3700 3700 3700 3700 3700 3700 3700 3700
CM0952A-IV-i-c-4 : Multiagent Chemotherapy + TKIs MAINTENANCE MEDICAL ONCOLOGY 3410 3410 3410 3410 3410 3410 3410 3410
CM0952A-IV-i-c-5 : Imatinib MEDICAL ONCOLOGY 1525 1525 1525 1525 1525 1525 1525 1525
CM0952A-IV-i-c-6 : Nilotinib MEDICAL ONCOLOGY 17800 17800 17800 17800 17800 17800 17800 17800
CM0952A-IV-i-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-IV-ii : Ph(+) AYA (Age > 40 years) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-IV-ii-a-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3) MEDICAL ONCOLOGY 59429 59429 59429 59429 59429 59429 59429 59429
CM0952A-IV-ii-a-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4) MEDICAL ONCOLOGY 62380 62380 62380 62380 62380 62380 62380 62380
CM0952A-IV-ii-a-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7) MEDICAL ONCOLOGY 11469 11469 11469 11469 11469 11469 11469 11469
CM0952A-IV-ii-a-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8) MEDICAL ONCOLOGY 13420 13420 13420 13420 13420 13420 13420 13420
CM0952A-IV-ii-a-5 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction II MEDICAL ONCOLOGY 15133 15133 15133 15133 15133 15133 15133 15133
CM0952A-IV-ii-a-6 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction III MEDICAL ONCOLOGY 5535 5535 5535 5535 5535 5535 5535 5535
CM0952A-IV-ii-a-7 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Maintenance MEDICAL ONCOLOGY 9923 9923 9923 9923 9923 9923 9923 9923
CM0952A-IV-ii-b-1 : Multiagent Chemotherapy + TKIs INDUCTION PHASE MEDICAL ONCOLOGY 15573 15573 15573 15573 15573 15573 15573 15573
CM0952A-IV-ii-b-2 : Multiagent Chemotherapy + TKIs CONSOLIDATION I MEDICAL ONCOLOGY 12110 12110 12110 12110 12110 12110 12110 12110
CM0952A-IV-ii-b-3 : Multiagent Chemotherapy + TKIs CONSOLIDATION II MEDICAL ONCOLOGY 3200 3200 3200 3200 3200 3200 3200 3200
CM0952A-IV-ii-b-4 : Multiagent Chemotherapy + TKIs MAINTENANCE MEDICAL ONCOLOGY 6410 6410 6410 6410 6410 6410 6410 6410
CM0952A-IV-ii-b-5 : Imatinib MEDICAL ONCOLOGY 1525 1525 1525 1525 1525 1525 1525 1525
CM0952A-IV-ii-b-6 : Nilotinib MEDICAL ONCOLOGY 17800 17800 17800 17800 17800 17800 17800 17800
CM0952A-IV-ii-c : Corticosteroids + TKIs MEDICAL ONCOLOGY 9035 9035 9035 9035 9035 9035 9035 9035
CM0952A-IV-ii-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-IV-iii : Ph(-) AYA (Age 15-39 years) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-IV-iii-a-1 : GRAALL-2003 INDUCTION MEDICAL ONCOLOGY 15678 15678 15678 15678 15678 15678 15678 15678
CM0952A-IV-iii-a-2 : GRAALL-2003 SALVAGE MEDICAL ONCOLOGY 28760 28760 28760 28760 28760 28760 28760 28760
CM0952A-IV-iii-a-3 : GRAALL-2003 CONSOLIDATION MEDICAL ONCOLOGY 30779 30779 30779 30779 30779 30779 30779 30779
CM0952A-IV-iii-a-4 : GRAALL-2003 Late intensification between consolidation blocks 6 and 7 (for patients in complete remission [CR] after the first induction course) MEDICAL ONCOLOGY 15495 15495 15495 15495 15495 15495 15495 15495
CM0952A-IV-iii-a-5 : GRAALL-2003 Late intensification between consolidation blocks 6 and 7 (for patients in CR after salvage course) MEDICAL ONCOLOGY 27210 27210 27210 27210 27210 27210 27210 27210
CM0952A-IV-iii-a-6 : GRAALL-2003 Maintenance MEDICAL ONCOLOGY 56898 56898 56898 56898 56898 56898 56898 56898
CM0952A-IV-iii-b : CNS Therapy-Treatment of patients with initial CNS involvement: MEDICAL ONCOLOGY 21155 21155 21155 21155 21155 21155 21155 21155
CM0952A-IV-iii-v : CCG-1961 MEDICAL ONCOLOGY 18310 18310 18310 18310 18310 18310 18310 18310
CM0952A-IV-iii-vi : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0952A-IV-iv : Ph(-) AYA (Age > 40 years) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0952A-IV-iv-a-1 : CALGB 8811 (Larson Regimen) INDUCTION MEDICAL ONCOLOGY 18038 18038 18038 18038 18038 18038 18038 18038
CM0952A-IV-iv-a-2 : CALGB 8811 (Larson Regimen) CONSOLIDATION MEDICAL ONCOLOGY 16685 16685 16685 16685 16685 16685 16685 16685
CM0952A-IV-iv-b-1 : Hyper-CVAD with or without Rituximab CYCLE 1,3,5,7 MEDICAL ONCOLOGY 60970 60970 60970 60970 60970 60970 60970 60970
CM0952A-IV-iv-b-2 : Hyper-CVAD with or without Rituximab CYCLE 2,4,6,8 MEDICAL ONCOLOGY 56820 56820 56820 56820 56820 56820 56820 56820
CM0952A-IV-iii-c : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A : All Lymphoma Chemotheraphy MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-I : Hodgkins Lymphoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-I-a : ABVD MEDICAL ONCOLOGY 4480 4480 4480 4480 4480 4480 4480 4480
CM0953A-I-b : Escalated BEACOPP MEDICAL ONCOLOGY 7119 7119 7119 7119 7119 7119 7119 7119
CM0953A-I-c : ABVD + Rituximab (cyled every 4 weeks) MEDICAL ONCOLOGY 28480 28480 28480 28480 28480 28480 28480 28480
CM0953A-I-d-i : ABVD + Rituximab (1 cycle - weekly rituximab 4 doses) followed by ABVD MEDICAL ONCOLOGY 102480 102480 102480 102480 102480 102480 102480 102480
CM0953A-I-d-ii : ABVD MEDICAL ONCOLOGY 4480 4480 4480 4480 4480 4480 4480 4480
CM0953A-I-e-i : CHOP + Rituximab MEDICAL ONCOLOGY 26818 26818 26818 26818 26818 26818 26818 26818
CM0953A-I-e-ii : CHOP MEDICAL ONCOLOGY 2818 2818 2818 2818 2818 2818 2818 2818
CM0953A-I-f-i : CVP +/- Rituximab MEDICAL ONCOLOGY 25768 25768 25768 25768 25768 25768 25768 25768
CM0953A-I-f-ii : CVP MEDICAL ONCOLOGY 1768 1768 1768 1768 1768 1768 1768 1768
CM0953A-I-g : Rituximab MEDICAL ONCOLOGY 25500 25500 25500 25500 25500 25500 25500 25500
CM0953A-I-h : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-II : Waldenstrom's Macroglobulinemia/ Lymphoplasmacytic Lymphoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-II-a : Bortezomib + dexamethasone MEDICAL ONCOLOGY 68038 68038 68038 68038 68038 68038 68038 68038
CM0953A-II-b : Cyclophosphamide + doxorubicin + vincristine + prednisone + rituximab MEDICAL ONCOLOGY 26818 26818 26818 26818 26818 26818 26818 26818
CM0953A-II-c : Rituximab MEDICAL ONCOLOGY 25500 25500 25500 25500 25500 25500 25500 25500
CM0953A-II-d : Rituximab + cyclophosphamide + prednisone MEDICAL ONCOLOGY 25738 25738 25738 25738 25738 25738 25738 25738
CM0953A-II-e : Rituximab + cyclophosphamide + dexamethasone MEDICAL ONCOLOGY 25520 25520 25520 25520 25520 25520 25520 25520
CM0953A-II-f-i : Thalidomide with or without rituximab (Weeks 1 and 2) MEDICAL ONCOLOGY 2540 2540 2540 2540 2540 2540 2540 2540
CM0953A-II-f-ii : Thalidomide with or without rituximab (Weeks 3-50) MEDICAL ONCOLOGY 6000 6000 6000 6000 6000 6000 6000 6000
CM0953A-II-f-iii : Thalidomide with or without rituximab (Weeks 50-52) MEDICAL ONCOLOGY 6000 6000 6000 6000 6000 6000 6000 6000
CM0953A-II-f-iv : Thalidomide with or without rituximab Weeks 2-5 and 13-16 MEDICAL ONCOLOGY 24000 24000 24000 24000 24000 24000 24000 24000
CM0953A-II-g-i : Bendamustine with or without rituximab MEDICAL ONCOLOGY 36500 36500 36500 36500 36500 36500 36500 36500
CM0953A-II-g-ii : Bendamustine - rituximab MEDICAL ONCOLOGY 12500 12500 12500 12500 12500 12500 12500 12500
CM0953A-II-h-i : Cladribine with or without rituximab MEDICAL ONCOLOGY 32250 32250 32250 32250 32250 32250 32250 32250
CM0953A-II-h-ii : Cladribine - rituximab MEDICAL ONCOLOGY 8250 8250 8250 8250 8250 8250 8250 8250
CM0953A-II-i : Bendamustine MEDICAL ONCOLOGY 12500 12500 12500 12500 12500 12500 12500 12500
CM0953A-II-j : Chlorambucil MEDICAL ONCOLOGY 1126 1126 1126 1126 1126 1126 1126 1126
CM0953A-II-k : Fludarabine MEDICAL ONCOLOGY 12030 12030 12030 12030 12030 12030 12030 12030
CM0953A-II-l : Fludarabine + cyclophosphamide + rituximab (FCR) MEDICAL ONCOLOGY 32398 32398 32398 32398 32398 32398 32398 32398
CM0953A-II-m : Alemtuzumab MEDICAL ONCOLOGY 2650 2650 2650 2650 2650 2650 2650 2650
CM0953A-II-n : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III : NON HODGKINS LYMPHOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-i : BURKITT LYMPHOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-i-a -1 : CALGB 10002 Cycle 1: MEDICAL ONCOLOGY 8967 8967 8967 8967 8967 8967 8967 8967
CM0953A-III-i-a-2 : CALGB 10002 Cycles 2 (beginning Day 8), 4, and 6: MEDICAL ONCOLOGY 66113 66113 66113 66113 66113 66113 66113 66113
CM0953A-III-i-a-3 : CALGB 10002 Cycles 3, 5, and 7: MEDICAL ONCOLOGY 33108 33108 33108 33108 33108 33108 33108 33108
CM0953A-III-i-a-4 : CALGB 10002 Cycles 4, and 6: MEDICAL ONCOLOGY 36413 36413 36413 36413 36413 36413 36413 36413
CM0953A-III-i-b : CODOX-M (original or modified) (cyclophosphamide + doxorubicin + vincristine with intrathecal MTX + cytarabine, followed by systemic MTX and cytarabine) with or without Rituximab MEDICAL ONCOLOGY 46780 46780 46780 46780 46780 46780 46780 46780
CM0953A-III-i-c-1 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 1 & 2) MEDICAL ONCOLOGY 32972 32972 32972 32972 32972 32972 32972 32972
CM0953A-III-i-c-2 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 3-6) MEDICAL ONCOLOGY 32572 32572 32572 32572 32572 32572 32572 32572
CM0953A-III-i-d-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3) MEDICAL ONCOLOGY 59429 59429 59429 59429 59429 59429 59429 59429
CM0953A-III-i-d-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4) MEDICAL ONCOLOGY 61880 61880 61880 61880 61880 61880 61880 61880
CM0953A-III-i-d-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7) MEDICAL ONCOLOGY 10969 10969 10969 10969 10969 10969 10969 10969
CM0953A-III-i-d-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8) MEDICAL ONCOLOGY 12920 12920 12920 12920 12920 12920 12920 12920
CM0953A-III-i-e-1 : CODOX-M alternated with IVAC (CODOX-M) CODOX-M (original or modified) (cyclophosphamide + doxorubicin + vincristine, plus intrathecal MTX + cytarabine, followed by systemic MTX) alternating with IVAC (ifosfamide + cytarabine + etoposide) and intrathecal MTX with or without Rituximab MEDICAL ONCOLOGY 46780 46780 46780 46780 46780 46780 46780 46780
CM0953A-III-i-e-2 : CODOX-M alternated with IVAC (IVAC) CODOX-M (original or modified) (cyclophosphamide + doxorubicin + vincristine, plus intrathecal MTX + cytarabine, followed by systemic MTX) alternating with IVAC (ifosfamide + cytarabine + etoposide) and intrathecal MTX with or without Rituximab MEDICAL ONCOLOGY 42847 42847 42847 42847 42847 42847 42847 42847
CM0953A-III-i-f : RICE (rituximab + ifosfamide + carboplatin + etoposide) MEDICAL ONCOLOGY 32994 32994 32994 32994 32994 32994 32994 32994
CM0953A-III-i-g : RIVAC (rituximab + ifosfamide + cytarabine + etoposide) MEDICAL ONCOLOGY 43894 43894 43894 43894 43894 43894 43894 43894
CM0953A-III-i-h : RGDP (rituximab + gemcitabine + dexamethasone + cisplatin) MEDICAL ONCOLOGY 32255 32255 32255 32255 32255 32255 32255 32255
CM0953A-III-i-i : HDAC + Rituximab MEDICAL ONCOLOGY 27800 27800 27800 27800 27800 27800 27800 27800
CM0953A-III-i-ii : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III-ii : NON HODGKIN LYMPHOMA -- ADULT T-CELL LEUKEMIA / LYMPHOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-ii-a-1 : Zidovudine + alpha-interferon (induction) MEDICAL ONCOLOGY 4580 4580 4580 4580 4580 4580 4580 4580
CM0953A-III-ii-a-2 : Zidovudine + alpha-interferon (Maintenance Therapy) MEDICAL ONCOLOGY 2100 2100 2100 2100 2100 2100 2100 2100
CM0953A-III-ii-b : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) MEDICAL ONCOLOGY 2818 2818 2818 2818 2818 2818 2818 2818
CM0953A-III-ii-c : CHOEP MEDICAL ONCOLOGY 8640 8640 8640 8640 8640 8640 8640 8640
CM0953A-III-ii-d : Dose-adjusted EPOCH(etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) MEDICAL ONCOLOGY 6892 6892 6892 6892 6892 6892 6892 6892
CM0953A-III-ii-e : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III-iii : DIFFUSE LARGE B CELL LYMPHOMA MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-iii-a : CDE (cyclophosphamide + doxorubicin + etoposide) + rituximab MEDICAL ONCOLOGY 2500 2500 2500 2500 2500 2500 2500 2500
CM0953A-III-iii-b-1 : CODOX-M alternated with IVAC (CODOX-M) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine) MEDICAL ONCOLOGY 46780 46780 46780 46780 46780 46780 46780 46780
CM0953A-III-iii-b-2 : CODOX-M alternated with IVAC (IVAC) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine) MEDICAL ONCOLOGY 42847 42847 42847 42847 42847 42847 42847 42847
CM0953A-III-iii-c-1 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 1&2) MEDICAL ONCOLOGY 32972 32972 32972 32972 32972 32972 32972 32972
CM0953A-III-iii-c-2 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 3-6) MEDICAL ONCOLOGY 32572 32572 32572 32572 32572 32572 32572 32572
CM0953A-III-iii-d-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3) MEDICAL ONCOLOGY 59429 59429 59429 59429 59429 59429 59429 59429
CM0953A-III-iii-d-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4) MEDICAL ONCOLOGY 61880 61880 61880 61880 61880 61880 61880 61880
CM0953A-III-iii-d-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7) MEDICAL ONCOLOGY 10969 10969 10969 10969 10969 10969 10969 10969
CM0953A-III-iii-d-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8) MEDICAL ONCOLOGY 12920 12920 12920 12920 12920 12920 12920 12920
CM0953A-III-iii-e-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) Rituximab MEDICAL ONCOLOGY 26818 26818 26818 26818 26818 26818 26818 26818
CM0953A-III-iii-e-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) MEDICAL ONCOLOGY 2818 2818 2818 2818 2818 2818 2818 2818
CM0953A-III-iii-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III-iv : AIDS-Related B-Cell Lymphomas MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-iv-a : CDE (cyclophosphamide + doxorubicin + etoposide) + rituximab MEDICAL ONCOLOGY 2500 2500 2500 2500 2500 2500 2500 2500
CM0953A-III-iv-b-1 : CODOX-M alternated with IVAC (CODOX-M) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine) MEDICAL ONCOLOGY 46780 46780 46780 46780 46780 46780 46780 46780
CM0953A-III-iv-b-2 : CODOX-M alternated with IVAC (IVAC) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine) MEDICAL ONCOLOGY 42847 42847 42847 42847 42847 42847 42847 42847
CM0953A-III-iv-c-1 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 1&2) MEDICAL ONCOLOGY 32972 32972 32972 32972 32972 32972 32972 32972
CM0953A-III-iv-c-2 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 3-6) MEDICAL ONCOLOGY 32572 32572 32572 32572 32572 32572 32572 32572
CM0953A-III-iv-d-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3) MEDICAL ONCOLOGY 59429 59429 59429 59429 59429 59429 59429 59429
CM0953A-III-iv-d-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4) MEDICAL ONCOLOGY 61880 61880 61880 61880 61880 61880 61880 61880
CM0953A-III-iv-d-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7) MEDICAL ONCOLOGY 10969 10969 10969 10969 10969 10969 10969 10969
CM0953A-III-iv-d-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8) MEDICAL ONCOLOGY 12920 12920 12920 12920 12920 12920 12920 12920
CM0953A-III-iv-e-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) with or without Rituximab MEDICAL ONCOLOGY 26818 26818 26818 26818 26818 26818 26818 26818
CM0953A-III-iv-e-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) MEDICAL ONCOLOGY 2818 2818 2818 2818 2818 2818 2818 2818
CM0953A-III-iv-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III-v : Primary Cutaneous Marginal Zone or Follicle Center Lymphoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-v-a-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) with or without Rituximab MEDICAL ONCOLOGY 26818 26818 26818 26818 26818 26818 26818 26818
CM0953A-III-v-a-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) MEDICAL ONCOLOGY 2818 2818 2818 2818 2818 2818 2818 2818
CM0953A-III-v-b : Rituximab MEDICAL ONCOLOGY 25500 25500 25500 25500 25500 25500 25500 25500
CM0953A-III-v-c : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III-vi : Follicular Lymphoma (Grade 1-2) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-vi-a-1 : Bendamustine with or without rituximab MEDICAL ONCOLOGY 36500 36500 36500 36500 36500 36500 36500 36500
CM0953A-III-vi-a-2 : Bendamustine (-) rituximab MEDICAL ONCOLOGY 12500 12500 12500 12500 12500 12500 12500 12500
CM0953A-III-vi-b-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) with or without Rituximab MEDICAL ONCOLOGY 26818 26818 26818 26818 26818 26818 26818 26818
CM0953A-III-vi-b-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) MEDICAL ONCOLOGY 2818 2818 2818 2818 2818 2818 2818 2818
CM0953A-III-vi-c : Cyclophosphamide + Vincristine + Prednisone + Rituximab (RCVP) MEDICAL ONCOLOGY 25768 25768 25768 25768 25768 25768 25768 25768
CM0953A-III-vi-d : Rituximab MEDICAL ONCOLOGY 25500 25500 25500 25500 25500 25500 25500 25500
CM0953A-III-vi-e : Lenalidomide + Rituximab MEDICAL ONCOLOGY 4940 4940 4940 4940 4940 4940 4940 4940
CM0953A-III-vi-f : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0953A-III-vii : Extranodal NK/T-Cell Lymphoma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0953A-III-vii-a : SMILE MEDICAL ONCOLOGY 27483 27483 27483 27483 27483 27483 27483 27483
CM0953A-III-vii-b : DeVIC +RT MEDICAL ONCOLOGY 9163 9163 9163 9163 9163 9163 9163 9163
CM0953A-III-vii-c : VIPID MEDICAL ONCOLOGY 6619 6619 6619 6619 6619 6619 6619 6619
CM0953A-III-vii-d : Other Regimen MEDICAL ONCOLOGY 10000 10000 10000 10000 10000 10000 10000 10000
CM0954 : Myelodysplastic Syndromes Treatment Regimens MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0954-i : Symptomatic Anemia With del(5q) with or without Other Cytogenetic Abnormalities MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0954-i-a : Lenalidomide MEDICAL ONCOLOGY 2575 2575 2575 2575 2575 2575 2575 2575
CM0954-ii : Symptomatic Anemia Without del(5q) and Serum Erythropoietin =500mU/mL MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0954-ii-a-1 : rHu-Epo with or without G-CSF MEDICAL ONCOLOGY 26080 26080 26080 26080 26080 26080 26080 26080
CM0954-ii-a-2 : rHu-Epo (-) G-CSF MEDICAL ONCOLOGY 25750 25750 25750 25750 25750 25750 25750 25750
CM0954-ii-b-1 : Darbepoetin alfa with or without G-CSF MEDICAL ONCOLOGY 9330 9330 9330 9330 9330 9330 9330 9330
CM0954-ii-b-2 : Darbepoetin alfa (-) G-CSF MEDICAL ONCOLOGY 9000 9000 9000 9000 9000 9000 9000 9000
CM0954-iii : Symptomatic Anemia Without del(5q), Serum Erythropoietin >500mU/mL, Unlikely to Respond to IST MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0954-iii-a-1 : Decitabine (15mg/m2) MEDICAL ONCOLOGY 15500 15500 15500 15500 15500 15500 15500 15500
CM0954-iii-a-2 : Decitabine (20mg/m2) MEDICAL ONCOLOGY 16500 16500 16500 16500 16500 16500 16500 16500
CM0954-iii-b : Lenalidomide MEDICAL ONCOLOGY 2575 2575 2575 2575 2575 2575 2575 2575
CM0955 : Multiple Myeloma MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0955-a : Lenalidomide (28 days) + Dexamethasone MEDICAL ONCOLOGY 6817 6817 6817 6817 6817 6817 6817 6817
CM0955-b : Lenalidomide (21 days) + Dexamethasone MEDICAL ONCOLOGY 5004 5004 5004 5004 5004 5004 5004 5004
CM0955-c : Lenalidomide MEDICAL ONCOLOGY 2575 2575 2575 2575 2575 2575 2575 2575
CM0955-d : Bendamustine + Lenalidomide + Dexamethasone MEDICAL ONCOLOGY 13639 13639 13639 13639 13639 13639 13639 13639
CM0955-e : Bendamustine MEDICAL ONCOLOGY 22000 22000 22000 22000 22000 22000 22000 22000
CM0955-f : Cyclophosphamide + Lenalidomide + Dexamethasone MEDICAL ONCOLOGY 5136 5136 5136 5136 5136 5136 5136 5136
CM0955-g : Dexamethasone + Cyclophosphamide + Etoposide + Cisplatin (DCEP) MEDICAL ONCOLOGY 5764 5764 5764 5764 5764 5764 5764 5764
CM0955-h : Dexamethasone + Thalidomide + Cisplatin + Doxorubicin + Cyclophosphamide + Etoposide (DT-PACE) MEDICAL ONCOLOGY 7724 7724 7724 7724 7724 7724 7724 7724
CM0955-i : High-dose Cyclophosphamide MEDICAL ONCOLOGY 5140 5140 5140 5140 5140 5140 5140 5140
CM0955-j : VAD / VAMP MEDICAL ONCOLOGY 6104 6104 6104 6104 6104 6104 6104 6104
CM0955-k : Melphalan MEDICAL ONCOLOGY 3900 3900 3900 3900 3900 3900 3900 3900
CM0955-l : Melphalan + Prednisolone MEDICAL ONCOLOGY 1137 1137 1137 1137 1137 1137 1137 1137
CM0955-m : Thalidomide + Dexamethasone MEDICAL ONCOLOGY 2376 2376 2376 2376 2376 2376 2376 2376
CM0955-n : Melphalan / Prednisolone/Thalidomide(MPT) MEDICAL ONCOLOGY 2257 2257 2257 2257 2257 2257 2257 2257
CM0956 : ALL LYMPHOMA SALVAGE CHEMO (Package 953 to be utilised) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0957 : CHILDHOOD B CELL LYMPHOMA VARIABLE REGIMEN (Package 953 to be utilised) MEDICAL ONCOLOGY 0 0 0 0 0 0 0 0
CM0100-N : BREAST CANCER - TAMOXIFEN MEDICAL ONCOLOGY 100 100 100 100 100 100 100 100
CM0100-O : BREAST CANCER - AROMATASE INHIBITORS MEDICAL ONCOLOGY 1000 1000 1000 1000 1000 1000 1000 1000
CM0100-P : BREAST CANCER - Zoledronic Acid for skeletal metastasis MEDICAL ONCOLOGY 2700 2700 2700 2700 2700 2700 2700 2700
CM0124-C : PROSTATE CANCER - Zoledronic Acid for skeletal metastasis MEDICAL ONCOLOGY 2700 2700 2700 2700 2700 2700 2700 2700
CM0955-O : Multiple Myeloma - Zoledronic Acid MEDICAL ONCOLOGY 2700 2700 2700 2700 2700 2700 2700 2700

Say hello to us , Toll-Free

1800 425 3993

Write to us

[email protected]

Reach us At

Project Office

Chief Minister's Comprehensive Health Insurance Scheme
No.226,Om Sakthi Towers,
Kilpauk Garden Road, Kilpauk,
Chennai-600010, Tamil Nadu

Visitors Count : 735 / 488621

Click here for old website